Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ICAM1+ neutrophils promote chronic inflammation via ASPRV1 in B cell–dependent autoimmune encephalomyelitis
Ryder F. Whittaker Hawkins, Alexandre Patenaude, Aline Dumas, Rajiv Jain, Yodit Tesfagiorgis, Steven Kerfoot, Takeshi Matsui, Matthias Gunzer, Patrice E. Poubelle, Catherine Larochelle, Martin Pelletier, Luc Vallières
Ryder F. Whittaker Hawkins, Alexandre Patenaude, Aline Dumas, Rajiv Jain, Yodit Tesfagiorgis, Steven Kerfoot, Takeshi Matsui, Matthias Gunzer, Patrice E. Poubelle, Catherine Larochelle, Martin Pelletier, Luc Vallières
View: Text | PDF
Research Article Neuroscience

ICAM1+ neutrophils promote chronic inflammation via ASPRV1 in B cell–dependent autoimmune encephalomyelitis

  • Text
  • PDF
Abstract

Neutrophils contribute to demyelinating autoimmune diseases, yet their phenotype and functions have been elusive to date. Here, we demonstrate that ICAM1 surface expression distinguishes extra- from intravascular neutrophils in the mouse CNS during experimental autoimmune encephalomyelitis (EAE). Transcriptomic analysis of these 2 subpopulations indicated that neutrophils, once extravasated, acquire macrophage-like properties, including the potential for immunostimulation and MHC class II–mediated antigen presentation. In corroboration, super-resolution (3D stimulated emission-depletion [STED]) microscopy revealed neutrophils forming synapses with T and B cells in situ. Further, neutrophils specifically express the aspartic retroviral-like protease ASPRV1, which increases in the CNS during EAE and severe cases of multiple sclerosis. Without ASPRV1, mice immunized with a new B cell–dependent myelin antigen (but not with the traditional myelin oligodendrocyte glycoprotein peptide) develop a chronic phase of EAE that is less severe and even completely fades in many individuals. Therefore, ICAM1+ macrophage–like neutrophils can play both shared and nonredundant roles in autoimmune demyelination, among them perpetuating inflammation via ASPRV1.

Authors

Ryder F. Whittaker Hawkins, Alexandre Patenaude, Aline Dumas, Rajiv Jain, Yodit Tesfagiorgis, Steven Kerfoot, Takeshi Matsui, Matthias Gunzer, Patrice E. Poubelle, Catherine Larochelle, Martin Pelletier, Luc Vallières

×

Figure 8

ASPRV1 is a neutrophil-specific marker increased in the CNS during EAE and severe forms of MS.

Options: View larger image (or click on image) Download as PowerPoint
ASPRV1 is a neutrophil-specific marker increased in the CNS during EAE a...
(A) Quantification of Asprv1 mRNA by qPCR in leukocytes isolated by FACS from the spinal cord of EAE mice at day 15 after induction. CD3ε+ T cells (T) were from either mice immunized with MOG35–55 (active EAE), mice transplanted with encephalitogenic T cells (passive EAE), or 2D2 mice that developed EAE after PTX injection. CD19+ B cells (B), CD45loCD11b+ microglia (Mic), CD45hiCD11b+CD11c+ DC, CD45hiCD11b+ macrophages (Mc), and Ly6G+ neutrophils expressing or not expressing ICAM1 (N+ and N–, respectively) were from mice with active EAE. n = 4 per group. (B) ASPRV1 protein (~32 kDa) detected by Western blotting in Percoll-enriched neutrophils from the BM of WT mice, but not of Asprv1–/– mice or in the mononuclear cell fraction from either genotype. Total loading per well: 20 μg protein. Actin (~42 kDa) was used as a control for protein loading. (C) Quantification of Asprv1 mRNA by qPCR in whole spinal cord from mice with different forms of EAE or from controls (i.e., mice treated with PBS, PTX, or CFA) and 2D2 mice that did not develop EAE after PTX injection (2D2 without EAE). Stars indicate significant differences from PBS, PTX, and CFA (for active and passive EAE) or from 2D2 without EAE (for 2D2 mice) at the same time point (Wilcoxon test, P < 0.018). n = 6 (PBS), 7–13 (PTX), 3–8 (CFA), 8 (active EAE), 8 (passive EAE), 6 (2D2 with EAE), and 5 (2D2 without EAE). (D) Spearman analysis showing a strong positive correlation between Asprv1 and Ly6g mRNA expression in the spinal cord during active EAE. n = 32. (E) qPCR analysis of ASPRV1 mRNA in freshly isolated human blood cells. Star indicates a significant difference from the other groups (Wilcoxon test, P = 0.0005). n = 2–10 per group. (F) qPCR analysis of ASPRV1 mRNA in postmortem brain samples from control individuals (normal) or patients with MS of varying degrees of severity (mild, moderate, or severe). NAWM, normal-appearing white matter. Star indicates a significant difference from the other groups (Wilcoxon test, P = 0.006). n = 13–16 per group.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts